首页 库珀医疗(usCOO)-基本信息

库珀医疗(usCOO)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:400.73

最高价:403.19

成交量:321268.0

昨收价:400.0

最低价:396.75

最新价:399.52

行情图标
概要信息

中文名称:库珀医疗


英文名称:Cooper


行业:医疗


简介:The Cooper Companies, Inc.是一家于1980组织成立的一家特拉华州的公司,是一家全球性的医疗产品公司,通过CooperVision公司和CooperSurgical 公司这两个业务部门提供专业的医疗保健市场


电话:1-925-4603600


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

库珀医疗,是一家全球性的医疗器械公司,业务遍布全球100多个国家,从事一系列隐形眼镜的开发、生产和销售,包括:球面镜片、以及复曲面和多焦点镜片,能够更正近期和远视(老花),解决各种复杂的视觉缺陷,如散光和老花眼。The Cooper Companies公司共分为2个部分来运作:库珀医疗(CooperVision,CVI)及CooperSurgical(CSI)两个业务部门营运。 CooperVision:为视力保健带来清晰的视野,为隐形眼镜使用者制作一系列广泛的高品质产品及提供专业医生的支援。 CooperSurgical:专注于提供女性保健临床家市场领先的产品与治疗方案,借以改善女性医疗保健。库珀医疗The Cooper Companies(COO)历史百科: 1958年,The Cooper Companies前身Martin H. Smith Co.创立; 1961年,重组成立Cooper Tinsley Laboratories, Inc.; 1967年,公司更名为Cooper Laboratories Inc.; 1979年,发布第一款隐形眼镜; 1980年代,Cooper Laboratories重组为3个集团:CooperVision、CooperCare、CooperBiomedical,一年后变成4个集团,新增加了Cooper Medical Devices Corp; 1987年,公司采用新名字Cooper Companies; 1990年代,通过复杂的收购和扩张,公司进入医疗设备和眼科药物领域。库珀医疗The Cooper Companies(COO)产品百科:一、CooperVision® MyDay® Avaira ClearSight: ClearSight 1 Day ClearSight 1 Day Toric Hydrasoft: Hydrasoft Sphere Hydrasoft Toric/Options Vertex: Vertex Sphere Vertex Toric Biofinity Expressions: Expressions Accents Expressions Colors Preference: Preference Sphere Preference Toric Preference Toric XR Biomedics: Biomedics 55 Premier Biomedics EP Biomedics Toric Biomedics XC Frequency: Frequency 38 Sphere Frequency 55 Aspheric Frequency 55 Multifocal Frequency 55 Sphere Frequency 55 Toric Frequency 55 Toric XR Proclear: Proclear 1 Day Proclear Multifocal Proclear Multifocal Toric Proclear Sphere Proclear Toric Proclear Toric XR Disposable lens Spherical lens Accessories Specialty lens: Toric lenses Cosmetic lenses Multifocal lenses Diagnostic products Surgical instruments二、CooperSurgical Obstetrics Vacuum Assist Delivery Devices Fetal Dopplers Antepartum Fetal Monitors Postpartum Products Miscellaneous Obstetrical Disposables Family Planning Wide-Seal Silicone Diaphragm Kits Surgical Solutions Fertility Assessment Intrauterine Insemination (IUI) General Examination Diagnostic Disposables Examination Instruments Miscellaneous Civic Care Colposcopy Systems Colposcopy Instruments LEEP Products and Accessories Cryosurgery Products Incontinence\Pelvic Floor Urodynamic System Pessaries Surgical General Surgery Products Gynecology Surgery Products Neonatal Infant Nasal Cannula Neonatal Endotracheal Tube Grip Neonatal Skin Barrier Neonatal Thermoregulation Neonatal Transport Products Assisted Reproduction R.G. Edwards Embryo Transfer Products SAGE® Oocyte Retrieval Needles SAGE® Media SAGE® Micromanipulation Media Intrauterine Insemination (IUI) Fertility Assessment Cryopreservation Media Andrology Media Other Products

交易日期 交易人 职位 类型 交易份额 价格
2019-06-23 Lindell (Jody S) Director Buy 3000 49.57
2019-06-23 Lindell (Jody S) Director Sell 3000 328.29
2019-06-18 Golden Randal General Counsel Sell 1154 328.16
2019-06-17 Ricupati (Agostino) Officer Buy 742 119.89
2019-06-17 Ricupati (Agostino) Officer Buy 2547 162.28
2019-06-17 Ricupati (Agostino) Officer Buy 833 131.60
2019-06-17 Ricupati (Agostino) Officer Buy 1410 175.31
2019-06-17 Ricupati (Agostino) Officer Sell 5532 326.67
2019-06-16 Petersmeyer (Gary S) Director Sell 355 323.92
2019-06-09 Weiss (Robert S) Director Sell 16419 324.39
2019-06-09 Weiss (Robert S) Director Sell 17106 322.58
2019-06-09 Weiss (Robert S) Director Sell 7221 325.34
2019-06-09 Weiss (Robert S) Director Sell 11410 323.54
2019-06-09 Weiss (Robert S) Director Buy 52156 162.28
2019-06-09 Rubenstein (Allan E) Director Gift 4 --
2019-06-05 Kalkstein (Michael H) Director Sell 3500 316.28
2019-06-05 Kalkstein (Michael H) Director Buy 3500 49.57
2019-06-05 Mcbride (Daniel G) Officer Buy 11981 119.89
2019-06-05 Mcbride (Daniel G) Officer Sell 11981 315.99
2019-06-03 Rubenstein (Allan E) Director Gift 13 --
2019-04-01 Lindell (Jody S) Director Sell 437 297.09
2019-03-31 Kalkstein (Michael H) Director Buy 437 --
2019-03-31 Rubenstein (Allan E) Director Buy 459 --
2019-03-31 Lindell (Jody S) Director Buy 437 --
2019-03-31 Lindell (Jody S) Director Sell 2263 296.12

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Northern Trust Corp 602699 1.22% 14293 2.43% 2019-03-31
MFS Investment Management KK 2252601 4.55% -536181 -19.23% 2019-03-31
Generation Investment Management LLP 2294797 4.64% -984311 -30.02% 2019-03-31
State Street Corporation 2310306 4.67% -101424 -4.21% 2019-03-31
HHG PLC 2834318 5.73% 112906 4.15% 2019-03-31
Janus Capital Management LLC 3033719 6.13% -7440 -0.24% 2019-07-31
BlackRock Inc 3784211 7.65% 51482 1.38% 2019-03-31
Vanguard Group Inc 5339111 10.79% 183146 3.55% 2019-03-31
T. Rowe Price Associates, Inc. 5770547 11.66% -257954 -4.28% 2019-03-31
Massachusetts Financial Services Company 2252601 4.55% -536181 -19.23% 2019-03-31
BlackRock Fund Advisors 1399685 2.83% -72947 -4.95% 2019-07-31
Vanguard Investments Australia Ltd 1378315 2.79% 12437 0.91% 2019-07-31
Findlay Park Partners LLP 612748 1.24% -126000 -17.06% 2019-03-31
Amundi Pioneer Asset Management, Inc. 633655 1.28% -138464 -17.93% 2019-03-31
Frontier Capital Management CO Inc 646561 1.31% -138026 -17.59% 2019-03-31
Putnam Investment Management, LLC 646624 1.31% -323107 -33.32% 2019-07-31
Fidelity International Ltd 654801 1.32% -178808 -21.45% 2019-03-31
Geode Capital Management, LLC 730384 1.48% -713208 -49.41% 2019-03-31
State Street Global Advisors 805245 1.63% 899 0.11% 2019-07-31
Veritas Asset Management LLP 981302 1.98% 429340 77.78% 2019-03-31
Northern Trust Investments N A 602699 1.22% 14293 2.43% 2019-03-31
MML Investment Advisers, LLC 631941 1.28% -23846 -3.64% 2019-06-30
Morningstar 618375 1.25% 613064 11543.29% 2019-06-30
BlackRock Japan Co Ltd 724852 1.46% 660 0.09% 2019-05-31
BlackRock Asset Management Canada Ltd 1565749 3.16% 626 0.04% 2019-05-31
Westfield Capital Management Company, LP 628427 1.27% -87885 -12.27% 2018-12-31
Bessemer Investment Management LLC 761555 1.54% 5828 0.77% 2018-09-30
Bessemer Group Inc 761555 1.54% 5828 0.77% 2018-09-30
SSGA Funds Management Inc 710379 1.44% -35784 -4.80% 2019-01-31
BlackRock Institutional Trust Company NA 1281919 2.61% -145396 -10.19% 2018-06-30
Fidelity Management & Research Company 794359 1.62% 34511 4.54% 2018-10-31
State Street Corp 2412967 4.91% 465244 23.89% 2018-06-30
Panagora Asset Management Inc 764460 1.56% 165217 27.57% 2018-03-31
Pioneer Investment Mgmt Inc 1035668 2.11% -18834 -1.79% 2018-06-30
State Street Global Advisors (Aus) Ltd 565005 1.15% 13543 2.46% 2018-09-12
UBS Asset Mgmt Americas Inc 562424 1.15% 81406 16.92% 2018-06-30
WCM Investment Management 471725 0.96% 77945 19.79% 2018-06-30
GE Asset Management Inc 458362 0.93% -24807 -5.13% 2018-07-31
Champlain Investment Partners, LLC 425990 0.87% 31455 7.97% 2018-06-30
NORGES BANK 537025 1.10% 77746 16.93% 2017-12-31
Schroder Investment Management North America Inc. 414626 0.85% 13442 3.35% 2017-12-31
Renaissance Technologies Corp 422848 0.87% 215448 103.88% 2017-12-31
Goldman Sachs Asset Management LP 396986 0.81% 70257 21.50% 2017-12-31
William Blair Investment Management, LLC 546907 1.12% 275261 101.33% 2017-09-30
MFS Investment Management K.K. 2662207 5.45% -1286549 -32.58% 2017-12-31
Adage Capital Partners Gp LLC 361800 0.74% 192800 114.08% 2017-09-30
Invesco PowerShares Capital Mgmt LLC 370121 0.76% 286570 342.99% 2017-06-30
Fidelity Management and Research Company 2822910 5.79% -365400 -11.46% 2016-09-30
Columbia Mangmt Investment Advisers, LLC 1504059 3.09% 275660 22.44% 2016-09-30
Fidelity Institutional Asset Management 663468 1.36% -37430 -5.34% 2016-09-30
Putnam Investment Management,LLC 511703 1.05% -55961 -9.86% 2016-09-30
Hermes Fund Managers (Singapore) Pte. Limited 422335 0.87% 156367 58.79% 2016-12-31
Westwood Holdings Group Inc 392672 0.81% -18692 -4.54% 2016-09-30
Vanguard Group, Inc. 2914718 1.00% 466413174 0.10% 1999-11-30
BlackRock, Inc. 3720060 1.00% 595284001 0.10% 1999-11-30
FMR LLC 6770374 1.00% 1083395247 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Vanguard Mid Cap Growth 255521 0.52% -50666 -16.55% 2019-03-31
SPDR 549676 1.11% 510 0.09% 2019-07-31
Findlay Park American Fund 612748 1.24% -- -- 2019-04-30
Vanguard 500 Index Fund 974120 1.97% 12610 1.31% 2019-06-30
Vanguard Mid-Cap Index Fund 1202732 2.43% 17803 1.50% 2019-06-30
Vanguard Total Stock Market Index Fund 1358417 2.74% 12434 0.92% 2019-06-30
Janus Mid Cap Growth Tr 1373983 2.78% -- -- 2019-06-30
Janus Henderson Enterprise Fund 1373983 2.78% -- -- 2019-06-30
T. Rowe Price Mid-Cap Growth Fund 2200000 4.45% -50000 -2.22% 2019-06-30
T. Rowe Price Instl Mid-Cap Eq Gr Fd 538000 1.09% -20000 -3.58% 2019-06-30
MassMutual Select Mid Cap Growth Fund 520140 1.05% -47761 -8.41% 2019-06-30
Vanguard Institutional Index Fund 462143 0.93% -2370 -0.51% 2019-06-30
iShares Edge MSCI Min Vol USA ETF 309838 0.63% 315 0.10% 2019-07-31
Vanguard Mid-Cap Growth Index Fund 314371 0.64% 12637 4.19% 2019-06-30
Vanguard Growth Index Fund 352812 0.71% 12084 3.55% 2019-06-30
iShares Core S&P 500 ETF 366327 0.74% -180 -0.05% 2019-07-30
T. Rowe Price Health Sciences Fund 367908 0.74% -54000 -12.80% 2019-06-30
Fidelity 400748 0.81% 7101 1.80% 2019-06-30
Champlain Mid Cap Fund, LLC 402790 0.81% 2170 0.54% 2019-06-30
JNL/T. Rowe Price Mid-Cap Growth Fund 421000 0.85% 3000 0.72% 2019-03-31
Putnam Sustainable Leaders Fund 269400 0.54% -3200 -1.17% 2019-03-31
APT Test -EU11 612748 1.24% 612748 -- 2019-05-27
iShares Core S&P US Total Market ETF 362426 0.73% 330 0.09% 2019-05-30
iShares S&P 500 ETF 362426 0.73% 330 0.09% 2019-05-30
iShares Core S&P 500 ETF (CAD-Hedged) 362426 0.73% 330 0.09% 2019-05-30
iShares Core MSCI Kokusai ETF 362426 0.73% 330 0.09% 2019-05-30
iShares MSCI World ETF 358436 0.73% -750 -0.21% 2019-04-25
LO Funds Generation Global 289189 0.59% -6641 -2.24% 2019-01-31
Health Care Select Sector SPDR 278031 0.56% -1848 -0.66% 2019-03-31
Old Westbury Small & Mid Cap Strat Fd 397190 0.80% -- -- 2018-10-31
OH Putnam Fidelity Spartan 500 Index 368136 0.75% 10653 2.98% 2019-01-31
Pioneer Fundamental Growth Fund 261058 0.53% -41913 -13.83% 2018-12-31
Elfun Trusts 270000 0.55% -25000 -8.47% 2018-12-31
T. Rowe Price Value Fund 331700 0.67% -134900 -28.91% 2018-09-30
Vanguard Institutional Index I 473838 0.97% 224 0.05% 2018-07-31
Pioneer Fundamental Growth A 322944 0.66% -- -- 2018-06-30
Vanguard Mid-Cap Growth ETF 297778 0.61% 1230 0.41% 2018-07-31
T. Rowe Price Mid-Cap Growth 2250000 4.58% 135000 6.38% 2018-06-30
Janus Enterprise D 1373315 2.80% 495509 56.45% 2018-06-30
Vanguard Total Stock Mkt Idx 1229504 2.50% 5156 0.42% 2018-07-31
Vanguard Mid Cap Index I 1159827 2.36% 5497 0.48% 2018-07-31
Vanguard 500 Index Inv 888171 1.81% 1254 0.14% 2018-07-31
MassMutual Select Mid Cap Gr Eq II A 551192 1.12% 103624 23.15% 2018-06-30
T. Rowe Price Instl Mid-Cap Equity Gr 548800 1.12% 42800 8.46% 2018-06-30
T. Rowe Price Value 466600 0.95% -52700 -10.15% 2018-06-30
T. Rowe Price Health Sciences 462408 0.94% -11300 -2.39% 2018-06-30
JNL/T. Rowe Price Mid-Cap Growth B 409000 0.83% 29000 7.63% 2018-06-30
Old Westbury Small & Mid Cap 397190 0.81% 45990 13.10% 2018-04-30
Vanguard Growth Index Inv 345281 0.70% -960 -0.28% 2018-07-31
Fidelity Spartan 326545 0.67% 3851 1.19% 2018-07-31
T. Rowe Price New America Growth 254585 0.52% -- -- 2018-03-31
Vanguard Mid Cap Growth Inv 256929 0.52% -330 -0.13% 2017-09-30
Janus Research D 250788 0.51% -- -- 2017-09-30
Baron Asset Retail 240000 0.49% -- -- 2017-09-30
Franklin Small-Mid Cap Growth A 295300 0.61% -- -- 2016-12-31
Columbia Contrarian Core Z 352129 0.72% -178078 -33.59% 2016-12-31
Prudential Jennison Mid Cap Growth A 371421 0.76% -2639 -0.71% 2016-12-31
MFS Massachusetts Investors Gr Stk A 395937 0.81% -5759 -1.43% 2016-12-31
Fidelity Advisor 592851 1.22% -- -- 2016-12-31
Fidelity® Select Health Care Portfolio 550000 1.10% 35000 6.80% 2015-09-30
Fidelity Advisor® New Insights Fund 592851 1.20% -- -- 2015-09-30
Victory Munder Mid-Cap Core Growth Fund 621200 1.30% -10800 -1.70% 2015-09-30
Prudential Jennison Mid Cap Growth 708327 1.50% 114486 19.30% 2015-09-30
Vanguard Extended Market Index Fund 498214 1.00% 5075 1.00% 2015-10-31
SPDR® S&P MIDCAP 400 ETF 497543 1.00% 22682 4.80% 2015-10-31
Vanguard Explorer Fund 467589 1.00% 33484 7.70% 2015-09-30
T. Rowe Price Institutional Mid-Cap Equi 391000 0.80% 6000 1.60% 2015-09-30
Fidelity® Select Medical Equip & Systems 390000 0.80% -- -- 2015-09-30
Fidelity® Mid-Cap Stock Fund 386865 0.80% -- -- 2015-09-30
iShares Core S&P Mid-Cap (AU) 845764 1.60% 1140 0.10% 2015-11-19

Daniel G. McBride Presently, Daniel G. McBride is Chief Operating Officer & Executive Vice President at The Cooper Cos., Inc. and President at CooperVision, Inc. (a subsidiary of The Cooper Cos., Inc.). In his past career Mr. McBride occupied the position of Attorney at Latham & Watkins LLP. Mr. McBride received an undergraduate degree from Santa Clara University and a graduate degree from Stanford University.
Brian George Andrews Presently, Brian George Andrews occupies the position of Chief Financial Officer, Treasurer & Senior VP at The Cooper Cos., Inc. and Vice President-Global Logistics & Service at CooperSurgical, Inc. (a subsidiary of The Cooper Cos., Inc.). He is also Vice President-Global Logistics & Service at CooperSurgical, Inc. and on the board of 5 other companies. He previously occupied the position of Treasurer of The Cooper Cos., Inc. He received an undergraduate degree from Columbia University.
Gary S. Petersmeyer Mr. Gary S. Petersmeyer is Chairman at Positive Coaching Alliance. He is on the Board of Directors at The Cooper Cos., Inc., Omnicell, Inc. and Percy's, Inc. Mr. Petersmeyer was previously employed as Chairman by Cardica, Inc., Chairman & Chief Executive Officer by Aesthetic Sciences Corp., President & Chief Operating Officer by Pherin Pharmaceuticals, Inc., Chief Executive Officer by Collagen Aesthetics, Inc., and President, Chief Executive Officer & Director by Collagen Corp. He also served on the board at AMO Manufacturing USA LLC and ROXRO Pharma, Inc. He received his undergraduate degree from Stanford University, a graduate degree from Harvard Graduate School of Education and an MBA from Harvard University.
A. Thomas Bender Presently, A. Thomas Bender holds the position of Chairman for The Cooper Cos., Inc. He is also on the board of Mission Hospital Foundation and Allegro Ophthalmics LLC. He previously occupied the position of President of CooperVision, Inc., President, Chief Operating Officer & Senior VP at Herbert Laboratories and Senior Vice President at Allergan, Inc. A. Thomas Bender received an undergraduate degree from the University of St. Thomas (Texas).
Michael H. Kalkstein Michael H. Kalkstein is on the board of The Cooper Cos., Inc. and Silicon Valley Capital Club. He previously occupied the position of Trustee & President at Opera San Jose, Partner at Dechert LLP, Member of Alliance of Chief Executives LLC, Partner at Oppenheimer Wolff & Donnelly LLP, Director-Northern California Chapter at NACD Northern California Chapter, Inc. and Director-Northern California Chapter at National Association of Corporate Directors.
Carol Rose Kaufman Ms. Carol R. Kaufman is an Independent Director at Insperity, Inc., a Secretary, Chief Administrative Officer & EVP at The Cooper Cos., Inc. and a Secretary & Vice President at CooperSurgical Acquisition Corp. She is on the Board of Directors at Reprogenetics Uk Ltd., Insperity, Inc., ORIGIO A/S, Research Instruments Ltd. and Sauflon Pharmaceuticals Ltd. Ms. Kaufman was previously employed as an Independent Director by Chindex International, Inc., a Secretary, Chief Administrative Officer & VP by Cooper Development Co., and a Deputy Corporate Controller by Cooper Laboratories, Inc. She received her undergraduate degree from Boston University.
Allan E. Rubenstein Allan E. Rubenstein founded Nexgenix Pharmaceuticals LLC. Currently, Dr. Rubenstein is Chairman of Plex Pharmaceuticals, Inc. Dr. Rubenstein is also on the board of The Cooper Cos., Inc. and Connecticut River Museum and Clinical Professor at NYU Langone Medical Center and Medical Director-Emeritus at Children's Tumor Foundation. Allan E. Rubenstein previously occupied the position of Chief Executive Officer of Nexgenix Pharmaceuticals LLC, Professor at NYU Elaine A. & Kenneth G. Langone Medical Center and Chairman-Army Neurofibromatosis Research at US Department of Defense (District of Columbia).
Allan E. Rubenstein Allan E. Rubenstein founded Nexgenix Pharmaceuticals LLC. Currently, Dr. Rubenstein is Chairman of Plex Pharmaceuticals, Inc. Dr. Rubenstein is also on the board of The Cooper Cos., Inc. and Connecticut River Museum and Clinical Professor at NYU Langone Medical Center and Medical Director-Emeritus at Children's Tumor Foundation. Allan E. Rubenstein previously occupied the position of Chief Executive Officer of Nexgenix Pharmaceuticals LLC, Professor at NYU Elaine A. & Kenneth G. Langone Medical Center and Chairman-Army Neurofibromatosis Research at US Department of Defense (District of Columbia).
William A. Kozy William A. Kozy is on the board of The Cooper Cos., Inc., Franciscan Sisters of the Poor Foundation, Inc. and LivaNova Plc. Mr. Kozy previously was Chief Operating Officer & Executive Vice President at Becton, Dickinson & Co. Mr. Kozy received an undergraduate degree from Kenyon College.
Gary S. Petersmeyer Gary S. Petersmeyer is a businessperson who founded Aesthetic Sciences Corp. and who has been the head of 6 different companies. He is on the board of The Cooper Cos., Inc., Omnicell, Inc. and Percy's, Inc. and Chairman for Positive Coaching Alliance. In the past Mr. Petersmeyer held the position of Chairman at Dextera Surgical, Inc., Chairman of Aesthetic Sciences Corp., President & Chief Operating Officer of Pherin Pharmaceuticals, Inc., President, Chief Executive Officer, COO & Director at Collagen Corp., Chief Executive Officer at Collagen Aesthetics, Inc. and Advisor at ROXRO Pharma, Inc. Gary S. Petersmeyer received an MBA from Harvard University, an undergraduate degree from Stanford University and a graduate degree from Harvard Graduate School of Education.
Jody S. Lindell Jody S. Lindell is President & Chief Executive Officer of S-G Management LLC. Ms. Lindell is also on the board of The Cooper Cos., Inc. In the past she was Audit Partner at KPMG LLP. She received an undergraduate degree from Stanford University and an MBA from Stanford Graduate School of Business.
Albert George White Albert George White is on the board of ORIGIO An and President, Chief Executive Officer & Director at The Cooper Cos., Inc. In his past career Mr. White occupied the position of Chief Executive Officer of Cooper Medical, Inc. He received an MBA and an undergraduate degree from Virginia Polytechnic Institute & State University.
Kim Duncan Currently, Kim Duncan is Vice President-Investor Relations of The Cooper Cos., Inc.
Holly Sheffield Holly Sheffield is Chief Strategy Officer & Executive Vice President at The Cooper Cos., Inc. In her past career Ms. Sheffield occupied the position of Managing Director & Head-Medical Technology at UBS Securities LLC and Managing Director-Investment Banking at UBS Ltd. She received an undergraduate degree from Cornell University and an MBA from Columbia Business School.
Colleen E. Jay Colleen E. Jay is on the board of The Cooper Cos., Inc. and Treasury Wine Estates Ltd. In the past she occupied the position of President-Beauty Specialty Businesses at Procter & Gamble Co. Vice President-Home Care & Global Strategic at Procter & Gamble Health & Beauty Care, Vice President-Fem Care, PCC & Oral Care at Procter & Gamble (China) Ltd. and General Manager-Health & Beauty Care at Procter & Gamble, Inc. (which are all subsidiaries of Procter & Gamble Co.). Colleen E. Jay received an undergraduate degree from Wilfrid Laurier University.
Randal Louis Golden Randal Louis Golden is Secretary, Vice President & General Counsel of The Cooper Cos., Inc. Mr. Golden is also Member of The State Bar of California and on the board of 5 other companies. In his past career Mr. Golden occupied the position of Senior Director & Legal Counsel at Align Technology, Inc., Principal at Verizon Wireless, Inc. and Director-Legal Affairs & Senior Counsel at Nokia, Inc. He received a graduate degree from the University of California, Los Angeles and an undergraduate degree from the University of Illinois.
Robert S. Weiss Robert S. Weiss is on the board of The Cooper Cos., Inc. (former President, Chief Executive Officer & Director), Accuray, Inc. and the University of Scranton. Dr. Weiss previously was President & Chief Operating Officer at CooperVision, Inc. Dr. Weiss received an undergraduate degree from the University of Scranton.
Agostino Ricupati Agostino Ricupati holds the position of Chief Accounting Officer & SVP-Finance & Tax at The Cooper Cos., Inc. Mr. Ricupati is also on the board of 6 other companies. Mr. Ricupati previously held the position of Director-International Tax at Intel Corp. Mr. Ricupati received a graduate degree from DePaul University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐